Literature DB >> 11053715

Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis.

T J Cleophas1, N Hornstra, B van Hoogstraten, J van der Meulen.   

Abstract

This meta-analysis suggests that homocysteine may not be as harmful for the heart as it seems. At the same time, however, homocysteine may be an indicator for unhealthy lifestyles, and therefore, an important variable for cardiologists to take into account when assessing coronary artery disease.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11053715     DOI： 10.1016/s0002-9149(00)01137-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  14 in total

Review 1.  Homocysteine and atherothrombosis: diagnosis and treatment.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

2.  The atherogenic effect of excess methionine intake.

Authors:  Aron M Troen; Esther Lutgens; Donald E Smith; Irwin H Rosenberg; Jacob Selhub
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

3.  Quality of systematic reviews of observational nontherapeutic studies.

Authors:  Tatyana Shamliyan; Robert L Kane; Stacy Jansen
Journal:  Prev Chronic Dis       Date:  2010-10-15       Impact factor: 2.830

4.  Hyperhomocysteinemia is an independent predictor of sub-clinical carotid vascular damage in subjects with grade-1 hypertension.

Authors:  Alberto Mazza; Stefano Cuppini; Laura Schiavon; Marco Zuin; Roberta Ravenni; Giulia Balbi; Domenico Montemurro; Giuseppe Opocher; Maria Rosa Pelizzo; Patrick M Colletti; Domenico Rubello
Journal:  Endocrine       Date:  2013-10-03       Impact factor: 3.633

5.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

Authors:  David S Wald; Malcolm Law; Joan K Morris
Journal:  BMJ       Date:  2002-11-23

6.  Vitamin B12 level in peripheral arterial disease.

Authors:  Katalin S Zsóri; Zoltán Csiki; Éva Katona; Zsuzsnna Bereczky; Amir-Houshang Shemirani
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

Review 7.  Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study.

Authors:  Ioanna Tzoulaki; Konstantinos C M Siontis; John P A Ioannidis
Journal:  BMJ       Date:  2011-11-07

8.  Differences in traditional and non-traditional risk factors with special reference to nutritional factors in patients with coronary artery disease with or without diabetes mellitus.

Authors:  Namita P Mahalle; M K Garg; Mohan V Kulkarni; Sadanand S Naik
Journal:  Indian J Endocrinol Metab       Date:  2013-09

9.  Plasma homocysteine is elevated in COPD patients and is related to COPD severity.

Authors:  Terence A R Seemungal; Johanna Cho Fook Lun; Gershwin Davis; Carlos Neblett; Nkhabe Chinyepi; Christina Dookhan; Samantha Drakes; Elizabeth Mandeville; Fatima Nana; Seatshogeng Setlhake; Celia Poon King; Lexley Pinto Pereira; Lexley PintoPereira; Jerome Delisle; Thomas M A Wilkinson; Jagwiga A Wedzicha
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 10.  Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels.

Authors:  Jutta Dierkes; Claus Luley; Sabine Westphal
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.